Fundraising Fox

Treo Ventures, LlcFull Portfolio

14 tracked investments · listed companies and verified rows first

CVRxcvrx.comin𝕏NASDAQ: CVRXJul 2020

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

Craig Palmer(Executive Officer)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)

BoardGeoff Pardo(Director)

Co-investorsNew Enterprise Associates (NEA)Windham Capital PartnersYsios CapitalHatteras Venture PartnersVensana Capital

Avivomedavivomed.com✓ verified

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.

BiotechDeep TechHealthtechMedical DevicesRoseville, US

Lynn Elliott(Co-Founder)Mudit Jain(Co-Founder)Paul Mazanec(Chief Executive Officer)Stephen Masson(Executive Officer, Director)

BoardTheresa C. Pappas(Director)Ketan Patel(Director)in

Co-investorsHatteras Venture PartnersF-Prime Capital

Iriva Medicalirivamedical.com✓ verified

iRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases.

BiotechHealthtechMedical DevicesMinneapolis, US

Mudit K. Jain(Co-Founder and Chairman of the Board)Lynn Elliott(Co-Founder and Director)Steve Masson(President & CEO)

Co-investorsHatteras Venture PartnersF-Prime Capital

NuXcelnuxcel.comOct 2024 · $66M✓ verified

NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.

Deep TechHealthtechMedical Devices

Co-investorsAmzak HealthAPERTURE Venture PartnersNorwest Venture PartnersOSF VenturesU.S. Venture Partners

Hyalexhyalex.comin𝕏Oct 2024

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

Carl Vause(Executive Officer, Director)Mira Sahney(Executive Officer, Director)David Myung(Director)

BoardMichael Hawkins(Director)Wende Hutton(Director)inWilliam Harrington(Director)in

Board seatBrad H. Vale· per SEC Form D

Co-investorsCanaan PartnersOUP (Osage University Partners)

Noctrix Healthnoctrixhealth.comJan 2021 · $40M

Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.

Digital HealthMedical DevicesWellness & FitnessPleasanton, US

Shri Raghunathan(Founder)in

Board seatMudit JainTracy Pappas· per SEC Form D

Co-investorsAngelini VenturesBlue Venture FundsOrbiMedZühlke VenturesBridge BankSandbox Clinical Ventures+1 more

ShiraTronicsshiratronics.cominSep 2024 · $66M

ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.

BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US

Robert Binney(Executive Officer, Director)

BoardJoyce Erony(Director)inZack Scott(Director)Brad Vale(Director)inCasey Tansey(Director)

Board seatBrad H. ValeMudit Jain· per SEC Form D

Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more

Intervene Incintervene-med.comin

InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions.

BiotechHealthtechMedical DevicesMountain View, US

Fletcher Wilson(Executive Officer, Director)

BoardThomas Fogarty(Director)Mel Schatz(Director)

Co-investorsLaunchCapitalRiverVest Venture PartnersEmergent Medical Partners, LLP

Intuity Medicalin𝕏

IT Asset Management Group provides IT asset disposition (ITAD), secure data destruction, and electronics recycling services for retired IT equipment.

Circular EconomyEnterprise Software

Co-investorsEmergent Medical Partners, LLP

Iveacareiveacare.comApr 2024 · $27.5M

IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.

Deep TechHealthtechMedical DevicesRoseville, US

Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)

BoardKirk Nielsen(Director)in

Co-investorsHatteras Venture PartnersVensana Capital

Neochordneochord.comin𝕏

NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation.

Advanced ManufacturingHealthtechMedical DevicesMaple Grove, US

Todd Berg(Executive Officer, Director)David H. Chung(Executive Officer, Director)Ron Nelson(Executive Officer)

BoardCasey Tansey(Director)Mudit K. Jain(Director)Andrew ElBardissi(Director)in

Co-investorsUS Venture PartnersDeerfield Management Company

Neuspera Medical, Inc.neuspera.comin𝕏

Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.

BiotechHealthtechMedical DevicesSan Jose, US

Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)Dave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)

Co-investorsCerity Partners VenturesForeground CapitalPortfoliaWindham Capital PartnersAction Potential Venture Capital Ltd.Vertex Ventures HC

Presspogopresspogo.com
SecondWave Systems, Inc.secondwaveus.comin

SecondWave Systems develops a noninvasive, wearable ultrasound stimulation device that modulates nerves, cells, and organs deep in the body for at-home treatment of conditions such as inflammation and pain.

Digital HealthHardwareMedical Devices

Anuj Bhardwaj(Chief Executive Officer)Hubert H. Lim(Chief Scientific Officer)Jeff Heyman(Chief Operating Officer)

Co-investorsScientific Health Development

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.